FFO reached $64.5 million in 2026Q1, maintaining a stable dividend payout ratio of 0.69 relative to AFFO despite rising maintenance capital expenditures of $2.9 million.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 246.77M | 240.23M | 208.17M | 184.45M | 185.34M | 210.86M | 232.15M | 240.96M | 207.87M | 197.32M | 177.22M | 164.43M | 126.14M | 104.19M | 86.27M | 76.85M | 77.54M | 69.21M | 67.13M | 66.53M | 57.8M | 59.01M | 57.09M | 68.03M | 66.09M | 59.76M | 63.61M | 73.43M | 84.93M | 89.94M | 76.71M |
| Operating CF Growth % | 63.82% | 15.4% | 12.86% | -0.48% | -12.1% | -9.17% | -3.65% | 15.92% | 5.34% | 11.35% | 7.78% | 30.35% | 21.07% | 20.78% | 12.25% | -0.89% | 12.04% | 3.1% | 0.91% | 15.09% | -2.04% | 3.36% | -16.08% | 2.94% | 10.59% | -6.05% | -13.38% | -13.54% | -5.57% | 17.24% | 38.97% |
| Operating CF / Revenue % | 61.25% | 63.46% | 62.11% | 57.67% | 66.62% | 70.59% | 69.75% | 75.75% | 70.56% | 70.81% | 71.32% | 71.81% | 71.06% | 88.43% | 88.98% | 92.93% | 98.91% | 107.77% | 106.55% | 106.77% | 38.35% | 37.49% | 36.7% | 41.87% | 38.47% | 42.94% | 43.12% | 55.99% | 83.03% | 81.63% | 77.15% |
| Net Income | 148.11M | 142.18M | 137.99M | 134.38M | 65.5M | 111.97M | 185.31M | 160.45M | 154.33M | 159.37M | 152.72M | 150.31M | 103.05M | 107.18M | 90.9M | 81.13M | 69.42M | 64.23M | 57.51M | 96.44M | 69.23M | 54.41M | 56.38M | 43.81M | 30.79M | -63K | 33.72M | 53.62M | 69.64M | 75.39M | 67.16M |
| Depreciation & Amortization | 88.38M | 83.84M | 74.34M | 69.97M | 70.88M | 80.8M | 83.15M | 76.82M | 75.79M | 72.96M | 63.13M | 56.63M | 40.69M | 20.91M | 16.98M | 11.99M | 11.2M | 8.62M | 7.94M | 11.72M | 11.81M | 12.6M | 14.45M | 15.38M | 16.38M | 14.66M | 14.17M | 11.48M | 8.96M | 8.04M | 6.83M |
| Stock-Based Compensation | 0 | 0 | 0 | 4.61M | 8.61M | 8.41M | 3.06M | 3.65M | 2.49M | 2.61M | 1.73M | 2.13M | 2.02M | 2.34M | 2.17M | 3.09M | 2.37M | 853K | 7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.07M | 6.95M | -1.6M | -27.8M | 43.04M | 39.16M | -32.64M | -19.48M | -30.02M | -27.28M | -23.91M | -25.03M | -16.46M | -9.82M | -8.27M | -3.88M | -3.87M | -157K | 388K | -38.3M | -14.11M | -2.83M | -9.14M | 5.26M | 12.71M | 29.34M | 6.64M | 19.73M | -1.71M | -1.46M | -6.81M |
| Working Capital Changes | 6.29M | 7.26M | -2.56M | 3.29M | -2.7M | -438K | -6.74M | 18.7M | -571K | -2.46M | 2.4M | 3.75M | -3.72M | 3.77M | -1.28M | -1.15M | 417K | -2.04M | -2.78M | -3.33M | -9.12M | -5.17M | -4.6M | 3.58M | 6.21M | 15.82M | 9.08M | -11.4M | 8.04M | 7.97M | 9.53M |
| Cash from Investing | -299.07M | -271.07M | -191.55M | -11.63M | 197.94M | 185.28M | -89.71M | -342.52M | -250.29M | -163.85M | -329.84M | -136.33M | -540.32M | -625.82M | -99.81M | -55.47M | -92.03M | -55.28M | 52.17M | 21.43M | 47.17M | 333K | 65.74M | 64.72M | 23.23M | 41.86M | 29.18M | -53.37M | -78.74M | 49.18M | -115.92M |
| Acquisitions (Net) | 1.75M | 1.75M | 1.17M | 0 | 11.74M | -187.54M | -875K | 643K | 0 | 0 | -17M | 114.52M | 0 | 0 | -8.31M | 0 | 6.25M | 0 | 0 | -14M | 24.21M | 14.45M | 4.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -363.1M | -345.18M | -202.61M | 0 | -86.17M | -119.12M | 0 | -327.42M | -238.75M | -217.76M | -483.41M | -8.46M | 0 | 0 | 0 | 0 | -12.42M | -4.78M | 0 | -361.46M | -11.06M | -22.08M | -1.02M | 0 | 0 | -23.74M | -41.46M | -55.34M | -135.78M | -115.88M | -153.08M |
| Sale of Investments | 82.97M | 92.33M | 25.63M | 0 | 288.17M | 306.65M | 0 | 2.9M | 4.35M | 18.18M | 59.61M | 57.41M | 0 | 0 | 125K | 12.86M | 9.56M | 30.89M | 56.18M | 347.25M | 16.85M | 14.8M | 10.82M | 405K | 6.28M | 17.92M | 13.12M | 0 | 0 | 0 | 0 |
| Other Investing | 0 | 0 | 0 | -7.89M | -11.17M | 185.34M | -88.68M | -643K | -102.64M | -6.68M | -22.43M | -185.27M | -4.54M | 7.89M | -91.63M | 7.47M | 3.33M | 175K | 42K | 52.13M | 19.66M | 5.42M | 53.23M | 74.33M | 33.52M | 49.62M | 60.73M | 16.29M | 97.76M | 188.91M | 105.06M |
| Cash from Financing | -60.03M | 23.96M | -14.74M | -169.72M | -401.25M | -402.99M | -111.76M | 107.32M | 44.26M | -35.05M | 144.16M | -18.1M | 406.15M | 523.77M | 6.83M | -8.16M | -28.57M | -68.46M | -94.42M | -171.42M | -59.68M | -88.09M | -55.31M | -82.13M | -59.86M | -135.27M | -62.27M | -23.75M | -50.7M | -77.6M | 40.48M |
| Dividends Paid | -173.02M | -169.7M | -156.51M | -156.24M | -161.77M | -182.9M | -194.58M | -179.74M | -165.39M | -153.04M | -138.3M | -124.66M | -100.65M | -85.14M | -78.92M | -67.89M | -66.52M | -64.55M | -85.52M | -67.44M | -52.55M | -53.26M | -48.65M | -43M | -41.1M | -1.88M | -51.06M | -73.76M | -75.76M | -73.58M | -64.48M |
| Common Dividends | -128.58M | -169.7M | -156.51M | -156.24M | -161.77M | -182.9M | -194.58M | -179.74M | -165.39M | -153.04M | -138.3M | -124.66M | -100.65M | -85.14M | -78.92M | -67.89M | -66.52M | -64.55M | -85.52M | -67.44M | -52.55M | -53.26M | -48.65M | -43M | -41.1M | -1.88M | -51.06M | -73.76M | -75.76M | -73.58M | -64.48M |
| Debt Issuance (Net) | 0 | 1000K | 1000K | -1000K | -1000K | -1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | 337K | -1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K |
| Share Repurchases | 0 | 0 | 0 | 0 | -151.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.62M | 0 | -3.53M | 0 | -578K | 0 | 0 | -7.77M | -3M | 0 | -33.25M | 0 | 0 |
| Other Financing | -6.49M | -2.14M | -7.9M | -1.05M | 5.86M | -68.45M | -6.1M | -1.06M | -141.01M | 57.49M | 104.05M | -344.9M | 467.31M | 96.03M | -179K | 59.73M | 37.95M | 78K | 245K | 0 | 0 | 0 | 0 | -39.92M | 0 | 0 | 20M | -30.3M | -56.59M | -27K | -284.93M |
| Net Change in Cash | -110.06M | -4.67M | 1.94M | 3.1M | -17.97M | -6.86M | 30.67M | 5.76M | 1.84M | -1.57M | -8.45M | 10M | -8.03M | 2.14M | -6.71M | 13.22M | -43.05M | -54.52M | 24.89M | -83.46M | 45.3M | -28.75M | 67.53M | 50.63M | 29.46M | -33.65M | 30.53M | -3.68M | -44.51M | 61.52M | 1.28M |
| Exchange Rate Effect | 2.27M | 2.21M | 57K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 19.62M | 24.29M | 22.35M | 21.52M | 39.48M | 46.34M | 15.67M | 9.91M | 8.07M | 4.64M | 13.29M | 3.29M | 11.31M | 9.17M | 15.89M | 2.66M | 45.72M | 100.24M | 75.36M | 158.81M | 132.47M | 161.22M | 93.69M | 43.06M | 13.6M | 47.25M | 16.72M | 20.41M | 64.92M | 3.4M | 2.12M |
| Cash at End | 24.95M | 19.62M | 24.29M | 24.62M | 21.52M | 39.48M | 46.34M | 15.67M | 9.91M | 3.06M | 4.83M | 13.29M | 3.29M | 11.31M | 9.17M | 15.89M | 2.66M | 45.72M | 100.24M | 75.36M | 177.76M | 132.47M | 161.22M | 93.69M | 43.06M | 13.6M | 47.25M | 16.72M | 20.41M | 64.92M | 3.4M |
| Free Cash Flow | 226.1M | 220.26M | 192.44M | 180.71M | 180.71M | 210.79M | 231.99M | 222.96M | 60.22M | 21.98M | -189.79M | 49.91M | -409.63M | -529.52M | 86.27M | 1.05M | -21.19M | -12.36M | 63.09M | 64.04M | 55.31M | 46.75M | 55.41M | 58.02M | 49.52M | 57.82M | 60.41M | 59.12M | 44.2M | 66.09M | 8.82M |
| FCF Growth % | 13.93% | 14.46% | 6.49% | -0% | -14.27% | -9.14% | 4.05% | 270.21% | 173.97% | 111.58% | -480.31% | 112.18% | 22.64% | -713.83% | 8131.49% | 104.95% | -71.5% | -119.59% | -1.49% | 15.79% | 18.31% | -15.64% | -4.5% | 17.17% | -14.36% | -4.28% | 2.19% | 33.73% | -33.11% | 649.21% | -80% |
| FCF / Revenue % | 56.12% | 58.19% | 57.41% | 56.5% | 64.96% | 70.57% | 69.71% | 70.09% | 20.44% | 7.89% | -76.38% | 21.79% | -230.76% | -449.41% | 88.98% | 1.27% | -27.03% | -19.24% | 100.13% | 102.77% | 36.69% | 29.7% | 35.62% | 35.71% | 28.83% | 41.55% | 40.95% | 45.07% | 43.21% | 59.98% | 8.87% |
SHOP transition operational volatility
According to the reported quarterly data, NHI maintained a consistent dividend payout ratio relative to AFFO, with the 2026Q1 ratio of 0.69 indicating that the company retains a significant buffer to support its distribution despite the ongoing strategic transition toward more operationally intensive SHOP assets.
The stability of the dividend coverage ratio suggests that management is successfully balancing capital allocation between shareholder returns and the funding of property-level improvements. Investors should monitor whether this payout ratio trends upward as the SHOP portfolio matures, as any sustained increase could signal a tightening of the cash flow cushion.
As evidenced by the consistent spread between Net Income and FFO, with FFO reaching $64.5 million in 2026Q1 compared to $40.1 million in Net Income, the company's earnings are heavily influenced by non-cash depreciation charges inherent in its healthcare real estate portfolio.
The persistent gap between GAAP earnings and FFO underscores the necessity of focusing on cash-based metrics to evaluate true performance. This distortion appears to be a structural feature of the business model rather than a sign of accounting volatility, though it warrants ongoing scrutiny as the asset mix shifts.
Based on the financial statements, maintenance capital expenditures reached $2.9 million in 2026Q1, reflecting a moderate increase in the capital intensity required to support the portfolio as the company integrates more SHOP assets that demand higher levels of recurring tenant improvements and facility maintenance.
The uptick in capital expenditures suggests that the transition to an operating model is beginning to impact the cash flow statement more directly than the previous NNN-heavy structure. Analysts should investigate whether these costs are stabilizing or if they represent a permanent increase in the required reinvestment rate for the portfolio.
Analysis of the cash flow statements indicates that FFO consistently tracks above GAAP operating cash flow, with the 2026Q1 FFO of $64.5 million exceeding the $53.4 million in operating cash flow, suggesting that the company's earnings quality is supported by stable, non-cash adjustments.
The relationship between FFO and operating cash flow appears to be well-aligned with historical norms for the sector. This suggests that the company is not currently relying on aggressive working capital management to inflate its reported cash earnings, which provides a degree of confidence in the sustainability of current cash flows.
Quick answers to the most common questions about buying NHI stock.
National Health Investors, Inc. (NHI) generated $240.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
National Health Investors, Inc. (NHI) generated $220.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
National Health Investors, Inc. (NHI) spent $20.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, National Health Investors, Inc. (NHI) returned $169.7M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.